|
EP3072595A1
|
|
Microfluidic sorting device
|
|
EP3006560A1
|
|
Miwi2 as a marker for spermatogonial stem cells and method for diagnosing spermatogonial stem cells based on said marker
|
|
EP2930549A1
|
|
An optical arrangement and method for imaging a sample
|
|
EP2916158A1
|
|
Microscope
|
|
CA2898696A1
|
|
Improved baculoviral expression system and methods of producing the same
|
|
GB201320733D0
|
|
Optical arrangement for imaging a sample
|
|
GB201320728D0
|
|
A removable objective lens arrangement
|
|
EP2805769A1
|
|
Methods for nano-scale single cell analysis
|
|
WO2013124425A1
|
|
A cell-permeable and selective activator of protein phosphatase-1
|
|
US2014349931A1
|
|
Detection and treatment of breast cancer
|
|
WO2013050529A2
|
|
Use of igf-1 in the stimulation of treg cell activity and the treatment autoimmune disorders
|
|
GB201212896D0
|
|
Giant array liposome for high-throughput lipid-protein interaction screening
|
|
GB201209924D0
|
|
Microfluids for metagenomics
|
|
CN110764242A
|
|
Light pad microscope for spatially resolved fluorescence correlation spectroscopy
|
|
GB201121556D0
|
|
Fly manipulating device
|
|
WO2012019765A1
|
|
Methods and systems for tracking samples and sample combinations
|
|
WO2011035922A2
|
|
Inhibitors of fgf2 phosphorylation and their use for treating angiogenesis-related diseases
|
|
EP2382190A1
|
|
Toluidine sulfonamides and their use as-inhibitors
|
|
WO2009124755A1
|
|
Compounds with novel medical uses and method of identifying such compounds
|
|
WO2009124756A1
|
|
Use of aprepitant and derivatives thereof for the treatment of cancer
|
